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Reliability of low-flow vasoreactivity in the brachial artery of adolescents 1 
ABSTRACT 2 
Purpose: Macrovascular endothelial function is commonly assessed using flow-mediated 3 
dilation (FMD) and is nitric oxide (NO) dependent. However, the vasoreactivity to low-flow 4 
during the FMD protocol may complement FMD interpretation. This study aimed to 5 
investigate in adolescents: 1) the day-to-day reliability of low-flow-mediated constriction (L-6 
FMC) and composite vessel reactivity (CVR); and 2) the relationship between L-FMC and 7 
FMD. 8 
Methods: A retrospective analysis of data on 27 adolescents (14.3 ± 0.6 y, 12 males) was 9 
performed. Participants had two repeat measures, on separate days, of macrovascular function 10 
using high-resolution ultrasound for assessment of L-FMC, FMD and CVR.  11 
Results: On average, the L-FMC response was vasoconstriction on both days (-0.59 ± 2.22 % 12 
and -0.16 ± 1.50 %, respectively). In contrast, an inconsistent response to low flow 13 
(vasoconstriction, dilation or no change) was observed on an individual level. Cohen’s Kappa 14 
revealed poor agreement for classifying the L-FMC measurement between visits (k=0.04, 15 
P>0.05). Assessment of the actual vessel diameter was robust with a coefficient of variation 16 
of 1.7 % (baseline and peak) and 2.7 % (low-flow). The between-day correlation coefficient 17 
between measures was r=0.18, r=0.96 and r=0.52 for L-FMC, FMD and CVR, respectively. 18 
No significant correlation between FMD and L-FMC was observed for either visit (r=-0.06 19 
and r=-0.07, respectively; P>0.05).  20 
Conclusion: In adolescents, the low-flow vasoreactivity is inconsistent between days. 21 
Whereas the actual vessel diameter is reproducible, the measurement of L-FMC and CVR has 22 
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poor between-day reliability compared to FMD. Finally, L-FMC and FMD are not 23 
significantly correlated. 24 
 25 
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 43 
INTRODUCTION 44 
Cardiovascular disease (CVD) is the major cause of non-communicable deaths worldwide 1. 45 
Although the clinical implications of CVD are not evident until later adulthood, its origins 46 
can be found in childhood 2. Endothelial dysfunction is the initial stage in the 47 
pathophysiology of atherosclerosis 3 and can be assessed non-invasively by flow-mediated 48 
dilation (FMD), typically performed at the brachial artery 4. The FMD technique is both 49 
accurate and reproducible 5 and guidelines of best practice are available 6,7. Briefly, the 50 
measurement of baseline artery diameter is followed by a 5 min period of cuff-induced local 51 
ischaemia. During this ischaemic time span, blood flow through the vessel is low followed by 52 
a period of high flow when the cuff is released. The peak arterial diameter post-occlusion is 53 
compared to baseline diameter and the change typically expressed as a percentage. The FMD 54 
response, which is nitric oxide (NO) dependent 8, has been subject to many investigations in 55 
children and adolescents, such as establishing endothelial function in children at risk of CVD 56 
4 or the benefits of exercise 9,10. 57 
The vasoreactivity to the low-flow condition during the cuff-occlusion phase of the FMD 58 
protocol has recently been subject to some investigation. When examined at the radial artery, 59 
studies consistently reported vasoconstriction during cuff-occlusion 11,12 which led to the term 60 
‘low-flow-mediated constriction’ (L-FMC). It has been suggested that low-flow 61 
vasoreactivity is complementary to the traditional FMD measure as it enhances prognostic 62 
value 12,13. Furthermore, measuring L-FMC may provide additional mechanistic insight of 63 
endothelial function as it is NO independent 12. Finally, the combination of FMD and L-FMC 64 
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to create a vasoactive range (composite vessel reactivity, CVR) may aid to establish a more 65 
comprehensive image of vascular health 12.  66 
Gori, et al. 14 described good repeatability of the L-FMC measurement on the radial artery 67 
(intraclass correlation coefficient (ICC) of 0.8) in 25 healthy young adults. In contrast to the 68 
radial artery, there is no homogeneous vasoreactivity to the low-flow condition in the brachial 69 
artery, with reports of vasodilation, vasoconstriction and no alteration 13,15-17. Bell, et al. 18 70 
reported good between-day reliability of the L-FMC measurement in the brachial artery of 71 
adults (ICC of 0.87). Additionally, Aizawa, et al. 15 reported a significant association between 72 
L-FMC and FMD in adults, suggesting that low-flow vasoreactivity contributes to the 73 
magnitude of the FMD response. In children, only Thijssen, et al. 19 have investigated L-FMC 74 
and found a significant[WC1], yet small (~ 0.04 mm), increase of the brachial artery diameter 75 
when compared to baseline. However, the low-flow vasodilation was only reported as a 76 
group mean and inter-individual differences were not presented. Furthermore, whereas the 77 
FMD measurement is reliable in adolescents 20, no previous study has assessed whether L-78 
FMC of the brachial artery is reliable between days or examined its relationship with FMD in 79 
adolescents. 80 
The aims of the study were to address the following in an adolescent population: 1) to 81 
describe the vasoreactivity to low flow at the brachial artery and to document the day-to-day 82 
reliability of L-FMC; and 2) to characterise the magnitude of the relationship between L-83 
FMC and FMD.  84 
 85 
METHODS 86 
Participants 87 
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The data of the current investigation were obtained retrospectively from previous work 88 
(reference[WC2]) and reanalysed statistically. An analysis of the low-flow data was not 89 
presented in previous publications. The original sample comprised 40 participants but 13 90 
participants were excluded from analysis due to poor image quality or movement during the 91 
low flow period. Therefore, relevant data for the current investigation were available on 92 
twenty-seven 12- to 15-year-old adolescents (twelve boys). The original investigations were 93 
approved by the institutional ethics committee and both participants and their parents 94 
provided written informed assent and consent, respectively, before commencement of the 95 
studies. Exclusion criteria involved the use of any medication or substance known to 96 
influence vascular function.  97 
 98 
Description and reliability of low-flow vasoreactivity  99 
On the first visit to the laboratory, body mass and height were measured to the nearest 0.1 kg 100 
and 0.1 cm, respectively, before participants were familiarized to all measurements. For the 101 
assessment of their fitness, participants performed a combined ramp and supramaximal 102 
exercise protocol 21 in order to determine maximal oxygen uptake (V̇O2max). Pulmonary V̇O2 103 
was monitored throughout the test (Cortex Metalyzer III B, Leipzig, Germany). All exercise 104 
was performed on an electronically braked cycle ergometer (Lode Excalibur Sport, 105 
Groningen, the Netherlands). Definitions of low fitness and overweight/obesity were made 106 
based on age- and sex-appropriate V̇O2max 22 and body mass index (BMI) 23 cut points, 107 
respectively. Participants’ pubertal status was determined by a self-assessment of secondary 108 
sexual characteristics using adapted drawings of the five stages of pubic hair development 24. 109 
 110 
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On two occasions separated by approximately one week, participants were transported to the 111 
laboratory at 08:00 h following a ~ 12 h overnight fast and then consumed 30 g of 112 
commercially available corn flakes with 130 mL of skimmed milk. The macronutrient 113 
contribution of this breakfast is unlikely to have influenced endothelial function 25. At 08:45 114 
h, participants rested in a darkened, temperature-controlled room (24° C) for 10 min before 115 
the assessment of vascular function.  116 
 117 
Vascular assessment 118 
High-resolution Doppler and B-mode images of the brachial artery were simultaneously 119 
acquired (Sequoia 512; Acuson; Siemens Corp, Aspen, CO, USA) with a 13 MHz linear 120 
array transducer in duplex mode, in accordance with recent guidelines 7 and our earlier work 121 
(reference). Following a 10 min acclimatization period to the temperature-controlled room 122 
(24° C) in the supine position, baseline arterial diameter was measured for 1.5 min. Low-flow 123 
brachial artery diameter was measured during the last 30 s of a 5 min ischaemic stimulus 11,15 124 
induced by rapid forearm pneumatic cuff inflation (Hokanson, Bellevue, WA, USA) to 220 125 
mmHg. Endothelium-dependent vasodilation of the brachial artery was measured for 3 min 126 
after the 5 min occlusion period. Baseline, low-flow and post-occlusion brachial artery 127 
diameters were assessed during end diastole using validated ECG-gating software (Medical 128 
Imaging Applications LLC, Coralville, IA, USA) 7,26. All analyses were performed by the 129 
same investigator. The estimated shear rate for the low-flow period was calculated by 130 
averaging shear during the last 30 s of cuff occlusion. The area under the curve for estimated 131 
shear rate for FMD was calculated from the time of cuff deflation until peak dilation (SRAUC) 132 
7. 133 
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Mean arterial diameter over 1.5 min before cuff-occlusion (baseline) and its associated 95 % 134 
confidence intervals (CI) were determined in order to classify L-FMC. L-FMC was 135 
calculated as mean diameter over the last 30 s of the low-flow period and defined as 136 
vasoconstriction (diameter < lower CI of mean baseline diameter), no response (diameter 137 
within CI of mean baseline diameter), and vasodilation (diameter > upper CI of mean 138 
baseline diameter). FMD, L-FMC, and CVR were calculated using the following equations: 139 
FMD (%) = (Peak post-occlusion diameter - Mean baseline diameter) / (Mean baseline 140 
diameter) x 100% 141 
L-FMC (%) = (Mean diameter during last 30 s of occlusion - Mean baseline diameter) / 142 
(Mean baseline diameter) x 100% 143 
CVR (%) = (Peak post-occlusion diameter - mean diameter during last 30 s of occlusion) / 144 
(Mean baseline diameter) x 100% 145 
 146 
Control for confounding variables 147 
With parental supervision, participants were asked to replicate their evening meal prior to 148 
each laboratory visit. Furthermore, they also completed a food diary during the 48 h period 149 
immediately preceding each visit, which were subsequently assessed for total energy and 150 
macronutrient intake (CompEat Pro; Nutrition Systems, Banbury, UK). Participants were also 151 
instructed to avoid strenuous exercise and wear a triaxial accelerometer on the wrist of their 152 
non-dominant hand (GENEActiv; Activinsights Ltd, Cambridge, UK) during the 48 h prior to 153 
each visit. Time spent performing moderate-to-vigorous physical activity was determined 154 
using validated cut points for paediatric groups 27. 155 
 156 
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 158 
Statistical analyses 159 
All data are presented as mean and standard deviation (SD) unless otherwise stated. Given 160 
the recent suggestion of adjusting FMD allometrically for baseline diameter 28, Pearson’s 161 
correlation coefficient (r) was applied to examine the relationship between both FMD and L-162 
FMC and baseline diameter. However, as there were no significant correlations between 163 
FMD and baseline diameter (r = -0.06 and r = 0.01, both P > 0.7) or L-FMC and baseline 164 
diameter (r = 0.01 and r = 0.1, all both P > 0.6), allometric scaling was not undertaken. 165 
Descriptive statistics and Cohen’s Kappa were employed to analyse the day-to-day reliability 166 
of the vasoreactivity (i.e. classified as vasoconstriction, vasodilation and no response) to the 167 
low-flow condition. The magnitude of agreement was classified according to Fleiss 29 with k 168 
> 0.75 as excellent, k between 0.40 and 0.75 as fair to good and k < 0.40 as poor agreement. 169 
The reliability of the vascular measurements was examined using the typical error (TE), the 170 
TE expressed as a coefficient of variation (CV) and the ICC 30. Pearson’s correlation 171 
coefficient (r) was employed for the analysis of the relationship between L-FMC and FMD. 172 
Statistical significance was accepted when P < 0.05. IBM SPSS Statistics software (Version 173 
22; IBM Corporation, Armonk, NY) was used for all statistical analyses. 174 
 175 
RESULTS 176 
Characteristics for participants (n = 27) are presented in Table 1. Maturation status for boys 177 
and girls was as follows: Tanner stage 2, n = 1 and 0, stage 3, n = 6 and 1, stage 4, n = 3 and 178 
11, stage 5, n = 2 and 3, respectively. No significant mean differences in total energy intake, 179 
9 
 
individual macronutrient contribution, or time spent performing moderate-to-vigorous 180 
physical activity were apparent during the 48 h preceding each visit (all P > 0.05, data not 181 
reported). 182 
The reproducibility of macrovascular outcomes is illustrated in Table 2. The average 183 
response on visit 1 was vasoconstriction (-0.59 ± 2.22 % of baseline diameter), which was 184 
observed in 15 participants (56.6 %). Vasodilation was apparent in eight participants (29.6 185 
%), and four (14.8 %) did not show any response to the low-flow condition. On the second 186 
visit, participants demonstrated on average vasoconstriction (-0.16 ± 1.50 % of baseline 187 
diameter). In contrast to visit 1, 12 participants (44.4 %) showed vasoconstriction on the 188 
second visit, while vasodilation was exhibited by 10 participants (37.0 %). No alteration in 189 
vasoreactivity during cuff inflation was apparent in 5 participants (18.5 %). Eleven 190 
participants (40.7 %) presented the same low-flow vasoreactivity response on both visits. 191 
Cohen’s Kappa revealed a poor agreement for the classification of L-FMC between 192 
measurements (k = 0.04, P = 0.79). Average shear rate during the low-flow period was 191.3 193 
± 71.1 cm∙s-1 (visit 1) and 201.4 ± 96.9 cm∙s-1 (visit 2), respectively. SRAUC was 739.9 ± 194 
277.4 (visit 1) and 674.7 ± 209.3 (visit 2), respectively. There was no significant correlation 195 
between L-FMC and FMD on visit 1 (r = -0.06, P = 0.75) or on visit 2 (r = -0.07, P = 0.72) 196 
(Figure 1).  197 
 198 
DISCUSSION 199 
The current investigation is the first study to show that the average L-FMC response in the 200 
brachial artery in an adolescent population is vasoconstriction. However, the response is 201 
variable between participants and its subsequent classification into ‘vasoconstriction’, ‘no 202 
response’ or ‘vasodilation’ is not reliable between days. Compared to FMD and CVR, the 203 
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measurement of L-FMC also has a poorer reliability in adolescents. Nevertheless, this study 204 
supports the view that the measurement of L-FMC may add complementary information to 205 
the FMD measurement due to the lack of a significant correlation between them.  206 
Previous studies have shown that the vascular response to low flow is artery specific 17 and 207 
the reactivity in the brachial artery is non-uniform in adults 13,15,16. The only study concerned 208 
with low-flow vasoreactivity in a paediatric population reported vasodilation (~ 0.04 mm) of 209 
the brachial artery in children (9 – 10 y) 19, however, individual responses were not reported. 210 
In the current study, vasoconstriction was apparent on both visits (-0.59 ± 2.22 % and -0.16 ± 211 
1.50 %, respectively) but an inconsistent reactivity to low flow was observed. Across visits 1 212 
and 2, vasoconstriction during low flow was apparent in the majority of participants (56.6 % 213 
and 44.4 %, respectively), followed by vasodilation (29.6 % and 37.0 %, respectively) and no 214 
response (14.8 % and 18.5 %, respectively).  215 
Gori, et al. 14 measured L-FMC in the radial artery on two separate occasions with ≥ 24 h 216 
between assessments and reported good reproducibility of the measurement with an ICC of 217 
0.80. With regards to the brachial artery, Spiro, et al. 13 investigated the within-day (2 h apart) 218 
reproducibility of L-FMC and FMD and found no significant differences in healthy young 219 
volunteers, concluding that L-FMC can be measured reliably. Furthermore, Bell, et al. 18 220 
reported an ICC of 0.87 for L-FMC between days in their laboratory, however, within a very 221 
small sample size (n = 5). These results concur with our findings in the brachial artery of 222 
adolescents showing no significant mean differences (i.e. absence of an order effect) in L-223 
FMC, FMD and CVR between-days. A possible explanation for this finding could be seen in 224 
the different methodological approaches regarding the assessment of reliability. The analysis 225 
by Spiro, et al. 13 is limited to a mean difference only and did not take into account the 226 
within-subject variation. The small sample size in the study by Bell, et al. 18may also act to 227 
inflate the ICC, especially for a heterogeneous sample. From a physiological perspective, a 228 
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possible explanation could be the age-related difference in arterial wall features, in particular 229 
the previously reported increase in arterial stiffness with advancing age 19,31,32. Furthermore, 230 
the general decrease in endothelial function with age 19,33 might also be considered to explain 231 
the difference between adults and adolescents.  232 
The measurement of the actual vessel diameter was robust with a CV of 1.7 % (baseline and 233 
peak diameter) and 2.7 % (low-flow diameter), respectively. However, when expressed as a 234 
change compared to baseline, L-FMC has inferior reliability compared to FMD and CVR. 235 
Due to the vasoconstrictive response on average to low-flow, a loglinear transformation for 236 
the calculation of a CV for L-FMC was not possible. However, the absolute TE for L-FMC 237 
was almost five times higher than that for FMD (1.74 % vs 0.36 %). Furthermore, the CV of 238 
28.8 % for the CVR suggests larger variation in L-FMC considering that CVR is the sum of 239 
the absolute values of L-FMC and FMD, and the CV for FMD was only 5 %. However, the 240 
CV of CVR is consistent with previous FMD guidelines which stated that a CV of 20-30 % 241 
for FMD is a satisfactory level of repeatability 6. Finally, there was a very strong correlation 242 
between the two FMD measurements (ICC = 0.95) in the current study whereas the 243 
correlation for L-FMC between days was weak (ICC = 0.17), resulting in a moderate 244 
correlation for CVR (ICC = 0.52). The inferior reproducibility of L-FMC may be due to the 245 
small magnitude of change, either positive or negative, in artery diameter during low flow 246 
and consequently presents considerable variation in L-FMC. In conclusion, despite excellent 247 
repeatability of the measurement of the low-flow diameter, the L-FMC measurement itself 248 
has poor reproducibility between-days in adolescents when compared to FMD and CVR. A 249 
practical consequence is that larger sample sizes will be needed in order to identify changes 250 
in the mean between conditions due to the greater noise caused by the large variation when 251 
contrasted to FMD and CVR.  252 
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Despite previous reports of non-uniform reactivity to low flow in the brachial artery 15,16,34 no 253 
study has explored whether the classification into ‘vasoconstriction’, ‘vasodilation’ and ‘no 254 
response’ is reliable. Harrison, et al. 16 reported a wide variation for L-FMC in healthy adults 255 
and adults with risk factors for coronary artery disease from -5.6 to 5.0 %. They concluded 256 
that the individual response to low flow ‘cannot be assumed to remain unchanged’ 16 but did 257 
not discuss this further. We showed that almost 60 % of the adolescent participants presented 258 
different responses to low flow and agreement between-days was poor 29. As a consequence, 259 
our data show poor reliability of the categorisation of the low-flow response on a day-to-day 260 
basis. This inconsistent classification likely contributed to the poorer reliability of L-FMC 261 
compared to FMD.  262 
While FMD measures the ability of the endothelium to recruit or stimulate vasomotor 263 
function following an increase in shear stress, only the L-FMC can measure the vascular 264 
response at rest, i.e. reduced shear stress 12. The two different measurements have been 265 
proposed to complement each other to provide an extensive overview of vasomotor function 266 
12. We did not find any significant correlation between L-FMC and FMD either on the first or 267 
the second visit, which is in agreement with the results of Gori, et al. 14 using the radial artery 268 
and in patients with coronary atherosclerosis using the brachial artery 13. These findings are 269 
likely to reflect observations that the measurement of L-FMC alongside FMD enhances 270 
prognostic value 12,13 and provides insight into NO-independent mechanisms of endothelial 271 
function. In contrast, others who measured L-FMC in the brachial artery reported a 272 
significant but weak to moderate correlations between L-FMC and FMD in healthy older 273 
adults (r = 0.41), those with increased CVD risk (r = 0.19) 15 or adults varying in age and 274 
coronary artery risk factors (r = 0.41) 16. However, the sample population in the 275 
aforementioned studies differed significantly from the participants in the present study in 276 
terms of age and health status. Another study has found an significant inverse correlation 277 
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between L-FMC and FMD in which FMD increased with larger L-FMC in healthy adults 13. 278 
However, the sample size in that study was relatively small (n = 10) and it appears that the 279 
direction of this correlation was caused by two of the participants[WC3].  280 
 281 
Conclusion 282 
On average, adolescents demonstrate vasoconstriction at the brachial artery during low flow. 283 
However, on an individual level adolescents present vasoconstriction, vasodilation or no 284 
change and these individual responses are not consistent between days. While the 285 
measurement of the vessel diameter in the low-flow condition has high reproducibility, the 286 
between-days assessment of L-FMC has poor reproducibility compared to FMD and CVR. 287 
No significant correlation was observed between L-FMC and FMD showinguggesting the 288 
former provides complementary information about vascular endothelial function. However, 289 
the poorer reliability of L-FMC compared to FMD and CVR indicates that larger samples 290 
sizes will be needed to detect a given effect[WC4], at least in adolescents.  291 
 292 
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Table 1. Participant characteristics. 397 
  
Participants (n = 27) 
Age (years) 14.3 ± 0.6 
Body mass (kg) 56.0 ± 11.0 
Height (m) 1.64 ± 0.09 
BMI (kg∙m-2) 20.7 ± 2.4 
Overweight (n (%)) 2 (7%) 
?̇?O2 max (mL∙min-1∙kg-1) 41.2 ± 6.7 
Low fit (n (%)) 10 (37%) 
BMI, body mass index; ?̇?O2 max, maximal oxygen uptake. Data are presented as mean ± SD.  398 
 399 
 400 
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Table 2. Reproducibility of macrovascular measurements. 
  
Visit 1  
Mean ± SD 
 
Visit 2  
Mean ± SD 
 
Change in mean 
 
P value 
 
Typical error 
 
Typical error as CV 
(%) 
 
ICC 
 
Baseline 
diameter (mm) 
 
3.17 ± 0.35 
 
3.18 ± 0.36 
 
0.01 
 
0.61 
 
0.06 
 
1.7 
 
0.98* 
 
Low-flow 
diameter (mm) 
 
3.15 ± 0.35 
 
3.17 ± 0.37 
 
0.02 
 
0.34 
 
0.09 
 
2.7 
 
0.94* 
 
Peak diameter 
(mm) 
 
3.44 ± 0.38 
 
3.44 ± 0.40 
 
0.01 
 
0.73 
 
0.06 
 
1.7 
 
0.98* 
 
FMD (%) 
 
8.42 ± 1.51 
 
8.34 ± 1.68 
 
-0.09 
 
0.39 
 
0.36 
 
5.0 
 
0.95* 
 
L-FMC (%) 
 
-0.59 ± 2.22 
 
-0.16 ± 1.50 
 
0.43 
 
0.37 
 
1.74 
 
# 
 
0.17 
 
CVR (%) 
 
9.02 ± 2.75 
 
8.51 ± 2.34 
 
-0.51 
 
0.31 
 
1.80 
 
28.8 
 
0.52* 
CV, coefficient of variation; ICC, intraclass correlation coefficient; FMD, flow-mediated dilation; L-FMC, low-flow-mediated constriction; 
CVR, composite vessel reactivity; # Negative values did not allow a loglinear transformation for the calculation of the typical error as CV (%); * 
significant correlation, P < 0.01
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Figure 1. Correlation between flow-mediated dilation (FMD) and low-flow-mediated 
constriction (L-FMC) on visit 1 (●) and visit 2 (○). The lines of best fit are emitted for clarity.  
 
 
 
 
 
